Article Text

other Versions

PDF
Sentinel lymph node biopsy in patients with a needle core biopsy diagnosis of DCIS – is it justified?
  1. Brendan Doyle (b.doyle{at}beatson.gla.ac.uk)
  1. Irish National Breast Screening Programme and Department of Histopathology, United Kingdom
    1. Muammer Al-Mudhaffer (muamer2000{at}hotmail.com)
    1. St. Vincent’s University Hospital, Dublin 4 and Department of Histopathology, Ireland
      1. Margaret M Kennedy
      1. St. Vincent’s University Hospital, Dublin 4 and Department of Histopathology, Ireland
        1. Anne O'Doherty
        1. Irish National Breast Screening Programme and Departments of Radiology, Ireland
          1. Fidelma Flanagan (fidelma.flanagan{at}cancerscreening.ie)
          1. St. Vincent’s University Hospital, Dublin 4 and Department of Radiology, Ireland
            1. Enda W McDermot
            1. Irish National Breast Screening Programme and Department of Surgery, Ireland
              1. Michael J Kerin
              1. St. Vincent’s University Hospital, Dublin 4 and Department of Surgery, Ireland
                1. Arnold D Hill
                1. Irish National Breast Screening Programme and Department of Surgery, Republic of Ireland
                  1. Cecily M Quinn (c.quinn{at}st-vincents.ie)
                  1. Irish National Breast Screening Programme and Department of Histopathology, Ireland

                    Abstract

                    Background: The incidence of ductal carcinoma in situ (DCIS) has increased markedly with the introduction of population based mammographic screening. DCIS is usually diagnosed non-operatively. Although sentinel lymph node biopsy (SNB) has become standard of care in patients with invasive breast carcinoma the use of SNB in patients with DCIS is controversial.

                    Aims: This study examines the justification for offering SNB at the time of primary surgery to patients with a needle core biopsy (NCB) diagnosis of DCIS.

                    Methods: A retrospective analysis of 145 patients, diagnosed with DCIS by NCB and who had SNB performed at the time of primary surgery, was performed. The study focussed on rates of SNB positivity and underestimation of invasive carcinoma by NCB, and sought to identify factors that might predict the presence of invasive carcinoma in the excision specimen.

                    Results: 7/145 patients (4.8%) had a positive sentinel lymph node (SN), 4 macrometastases and 3 micrometastases. 6/7 patients had invasive carcinoma in the final excision specimen. 55/145 patients (37.9%) with NCB diagnosis of DCIS had invasive carcinoma in the excision specimen. The median invasive tumour size was 6mm. A radiological mass and areas of invasion less than 1mm, amounting to “at least microinvasion” on NCB were predictive of invasive carcinoma in the excision specimen.

                    Conclusions: SNB positivity in pure DCIS is rare. In view of the high rate of underestimation of invasive carcinoma in patients with NCB diagnosis of DCIS in this study, SNB appears justified in this group of patients in our centres.

                    Statistics from Altmetric.com

                    Request permissions

                    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.